Literature DB >> 7630197

Expression of the flt3 receptor and its ligand on hematopoietic cells.

K Brasel1, S Escobar, R Anderberg, P de Vries, H J Gruss, S D Lyman.   

Abstract

Expression of the flt3 tyrosine kinase receptor and its ligand were examined on various murine and human hematopoietic cell lines. Surface expression of flt3 receptor and flt3 ligand were detected by flow cytometry using biotinylated human flt3 ligand or biotinylated soluble human flt3 receptor Fc fusion protein (flt3R-Fc), respectively. Flt3 receptor and ligand expression were also examined by Northern blot analysis. Flt3 receptor was expressed on the surface of only two of nine murine cell lines and nine of 15 human cell lines, with positive cells representing the B cell, early myeloid, and monocytic lineages. Staining for surface expression of the flt3 ligand revealed that seven of nine murine cell lines and nine of 15 human cell lines screened were positive by flow cytometry. All murine and human cell lines assayed were positive for flt3 ligand RNA expression by Northern blot analysis, but not all cell lines expressing flt3 ligand mRNA had detectable surface expression. Cells expressing the flt3 ligand were of the myeloid, B cell and T cell lineages at various stages of differentiation. Only the OCI-AML-5, NALM-6, and AML-193 cell lines coexpressed both surface flt3 receptor and ligand. The myeloid leukemic M1 cell terminally differentiate into macrophage-like cells under the influence of leukemia inhibitory factor (LIF). We found that LIF-stimulated M1 cells down-regulated surface expression and mRNA levels of the flt3 receptor, but up-regulated expression of the flt3 ligand. Although we could demonstrate that the flt3 receptor was functional in the M1 cell line, flt3 ligand could not induce the M1 cells to differentiate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7630197

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  22 in total

1.  Flt3 ligand expands CD103⁺ dendritic cells and FoxP3⁺ T regulatory cells, and attenuates Crohn's-like murine ileitis.

Authors:  Colm B Collins; Carol M Aherne; Eóin N McNamee; Matthew D P Lebsack; Holger Eltzschig; Paul Jedlicka; Jesús Rivera-Nieves
Journal:  Gut       Date:  2011-11-07       Impact factor: 23.059

2.  miR-590-5p, miR-219-5p, miR-15b and miR-628-5p are commonly regulated by IL-3, GM-CSF and G-CSF in acute myeloid leukemia.

Authors:  Amanda J Favreau; Pradeep Sathyanarayana
Journal:  Leuk Res       Date:  2011-10-19       Impact factor: 3.156

Review 3.  PROTACs: great opportunities for academia and industry.

Authors:  Xiuyun Sun; Hongying Gao; Yiqing Yang; Ming He; Yue Wu; Yugang Song; Yan Tong; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2019-12-24

4.  FLT3 ligand plasma levels in acute myeloid leukemia.

Authors:  Pierre Peterlin; Joelle Gaschet; Thierry Guillaume; Alice Garnier; Marion Eveillard; Amandine Le Bourgeois; Michel Cherel; Camille Debord; Yannick Le Bris; Olivier Theisen; Béatrice Mahé; Viviane Dubruille; Catherine Godon; Nelly Robillard; Soraya Wuilleme; Cyrille Touzeau; Thomas Gastinne; Nicolas Blin; Anne Lok; Antoine Bonnet; Steven Le Gouill; Philippe Moreau; Marie-C Béné; Patrice Chevallier
Journal:  Haematologica       Date:  2019-01-10       Impact factor: 9.941

5.  Nlrp3-dependent IL-1β inhibits CD103+ dendritic cell differentiation in the gut.

Authors:  Rachel Mak'Anyengo; Peter Duewell; Cornelia Reichl; Christine Hörth; Hans-Anton Lehr; Sandra Fischer; Thomas Clavel; Gerald Denk; Simon Hohenester; Sebastian Kobold; Stefan Endres; Max Schnurr; Christian Bauer
Journal:  JCI Insight       Date:  2018-03-08

6.  Vascular endothelial growth factor (VEGF) in Crohn's disease: increased production by peripheral blood mononuclear cells and decreased VEGF165 labeling of peripheral CD14+ monocytes.

Authors:  T Griga; S Werner; M Köller; A Tromm; B May
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

7.  Mobilization of CD34+ progenitor cells in association with decreased proliferation in the bone marrow of macaques after administration of the Fms-like tyrosine kinase 3 ligand.

Authors:  R Keith Reeves; Qing Wei; Patricia N Fultz
Journal:  Clin Vaccine Immunol       Date:  2010-06-16

8.  Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice.

Authors:  A Staffas; L S Arabanian; S Y Wei; A Jansson; S Ståhlman; P Johansson; L Fogelstrand; J Cammenga; F Kuchenbauer; L Palmqvist
Journal:  Oncogene       Date:  2016-09-12       Impact factor: 9.867

9.  Outcome of patients with FLT3-mutated acute myeloid leukemia in first relapse.

Authors:  Farhad Ravandi; Hagop Kantarjian; Stefan Faderl; Guillermo Garcia-Manero; Susan O'Brien; Charles Koller; Sherry Pierce; Mark Brandt; Deborah Kennedy; Jorge Cortes; Miloslav Beran
Journal:  Leuk Res       Date:  2009-10-29       Impact factor: 3.156

Review 10.  Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications.

Authors:  Shinichiro Takahashi
Journal:  J Hematol Oncol       Date:  2011-04-01       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.